PIK3C3 and breast cancer: Ultimately, targeting dormancy-specific vulnerabilities directly, such as the dependence on PIK3C3-mTORC1 signaling in dormancy-prone breast cancer cells [1] could lead to either cell death or re-sensitization to conventional immune attack.